## Core Concept
The question tests the understanding of drug interactions with radiotherapy and the concept of radiation toxicity. Radiation toxicity can occur when certain drugs interact with radiation therapy, increasing the risk of adverse effects. The correct answer involves a drug that requires dose adjustment to prevent such toxicity.

## Why the Correct Answer is Right
The correct answer, **Bleomycin**, is a chemotherapeutic agent known to cause pulmonary toxicity, which can be exacerbated by radiation therapy, particularly when radiation fields include the lungs. The mechanism involves the generation of free radicals by bleomycin, leading to DNA damage and pulmonary fibrosis. During radiotherapy, especially when the lungs are in the radiation field, the risk of pulmonary toxicity increases, necessitating a dose adjustment of bleomycin to prevent radiation toxicity.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because no specific drug is mentioned, making it impossible to assess its relevance to radiation toxicity.
- **Option B:** Without a specific drug mentioned, it's challenging to evaluate its interaction with radiotherapy.
- **Option C:** Similarly, this option lacks specificity, preventing an accurate assessment of its potential for radiation toxicity.

## Clinical Pearl / High-Yield Fact
A crucial point to remember is that **bleomycin** can cause severe pulmonary fibrosis, a risk that is significantly increased when patients receive concurrent or sequential radiation therapy that includes the lungs in the radiation field. This interaction is critical in oncology and requires careful consideration to prevent severe toxicity.

## Correct Answer Line
**Correct Answer: C. Bleomycin**.